Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could your local pharmacy become a hearing care hub?

NCT ID NCT06864273

Knowledge-focused Sponsor: University of Alabama, Tuscaloosa Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 07, 2026 · Last updated Aug 07, 2026

Summary

This study tests whether pharmacy technicians in rural Alabama and Mississippi can be trained to help adults with mild-to-moderate hearing loss use over-the-counter hearing aids. Technicians will go through a step-by-step training program, and adults with hearing loss will report on the care they receive. The goal is to see if this approach can improve access to hearing healthcare in areas where audiologists are scarce.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Pharmacy Technician Educational Training
What this could lead to
If successful, this could create a new model where pharmacy technicians help rural adults access hearing care, potentially improving quality of life and expanding hearing healthcare access.
What could go wrong
This is an early-stage study focused on training and satisfaction, not on proving long-term hearing benefits. Results may not generalize beyond the specific rural communities studied.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 144 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jul 2025

Expected to finish

Aug 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Pharmacy technicians licensed to practice in the state of Alabama or Mississippi. 2. Pharmacy technicians who practice in rural communities of Alabama and Mississippi. 3. Adults 18 years of age with mild to moderate hearing loss and who live in rural communities of Alabama or Mississippi. Exclusion Criteria: 1. Pharmacy technicians with hearing loss who could have prior understanding of care for those with hearing loss will not be included in the study. 2. Adults 18 years of age or older with typical hearing will not be included in the study. 3. Adults with hearing loss who live in urban areas of Alabama and Mississippi will not be included in the study. 4. Participants will be excluded if they have any medical condition resulting in cognitive impairment that results in an inability to complete the study tasks (e.g., mental health condition, stroke, head injury, dementia, or Alzheimer's disease)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Bilateral hearing loss are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

AIDS hearing loss disorder Hearing Loss, Bilateral

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Bilateral hearing loss Health services research

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    2 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • The Department of Communicative Disorders

    RECRUITING

    Tuscaloosa, Alabama, 35487-0242, United States

  • The Department of Communicative Disorders, Box 870242

    RECRUITING

    Tuscaloosa, Alabama, 35487-0242, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.